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Abstract
Background: Air pollution is associated with a high burden or morbidity and mortality, but exposure cannot be
quantified rapidly or cheaply. The particulate burden of macrophages from induced sputum may provide a
biomarker. We compare the feasibility of two methods for digital quantification of airway macrophage particulate
load.
Methods: Induced sputum samples were processed and analysed using ImageJ and Image SXM software packages.
We compare each package by resources and time required.
Results: 13 adequate samples were obtained from 21 patients. Median particulate load was 0.38 μm2 (ImageJ) and
4.0 % of the total cellular area of macrophages (Image SXM), with no correlation between results obtained using
the two methods (correlation coefficient = −0.42, p = 0.256). Image SXM took longer than ImageJ (median 26 vs 54
mins per participant, p = 0.008) and was less accurate based on visual assessment of the output images. ImageJ’s
method is subjective and requires well-trained staff.
Conclusion: Induced sputum has limited application as a screening tool due to the resources required. Limitations
of both methods compared here were found: the heterogeneity of induced sputum appearances makes automated
image analysis challenging. Further work should refine methodologies and assess inter- and intra-observer reliability,
if these methods are to be developed for investigating the relationship of particulate and inflammatory response in
the macrophage.
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Background
Indoor and outdoor air pollution are the 4th and 9th
leading risk factors, respectively, for disability-adjusted
life years worldwide [1], and exposure is associated with
increased risk of pneumonia in children, respiratory can-
cers, and development of Chronic Obstructive Pulmon-
ary Disease [2–5]. Airborne particulate matter [6] with
an aerodynamic diameter of <2.5 μm (PM2.5) is consid-
ered particularly harmful as the small size allows inhal-
ation deep into the lungs [7].
Global initiatives, such as the Global Alliance for
Clean Cookstoves (www.cleancookstoves.org), are
tackling the major health burden caused by airborne
PM. Major randomised trials of the health effects of
clean burning cookstoves are in progress (e.g.
www.capstudy.org and http://www.kintampo-hrc.org/
projects/graphs.asp#.VMtKusaI0Rk). All share the chal-
lenge that quantifying an individual’s exposure to pollution
is complex and expensive, and there is no gold standard
method [8].
Development of a biomarker that acts as a surrogate
marker of exposure could obviate the need for costly
and intensive exposure monitoring. Ideally a biomarker
should be: closely associated with exposure, adequately
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sensitive and specific, consistent across heterogenous
populations, cost efficient, acceptable to the user popula-
tion, and feasible for use in the field (including low-
resource settings) [9].
The phagocytic action of airway macrophages (AM)
may provide the basis for a biomarker of PM exposure.
The particulate load within AM is: increased in individ-
uals who report exposure to household air pollution
compared to those who do not [10]; statistically different
between individuals who use different types of domestic
fuel [11]; and associated with exposure to outdoor PM
in commuters who cycle in London [12]. Correlation be-
tween AM particulate load (AMPL) and worsening lung
function supports a possible pathophysiological role
[13]. A recent systematic review of studies calculating
AMPL concluded that this biomarker is suitable for
assessing personal exposure to PM, but that technical
improvements are needed before this method is suitable
for widespread use [14].
Once cell monolayers (Cytospins™) have been obtained
from induced sputum (IS) or bronchoalveolar lavage
(BAL) samples, several different digital image analysis
software programmes can be used to calculate AMPL.
ImageJ software (http://rsbweb.nih.gov/ij/, superseding a
similar software, Scion Image) and Image SXM software
[15] (http://www.ImageSXM.org.uk) have both been
used for this purpose [12, 16, 17].
There is no previously reported objective comparison
of their feasibility and it is unknown whether these two
methods provide comparable results. Unlike ImageJ,
Image SXM has only been used with samples obtained
via BAL, a technique that is not suitable for widespread
use in the field due to the expertise, risks and financial
costs involved. This study therefore aimed to provide an
objective assessment of the relative feasibilities – with
regard to resources, expertise and time required - of
ImageJ and Image SXM for use with IS samples, and
their comparative accuracy.
Methods
Participant involvement
Respiratory patients were recruited via outpatient respira-
tory clinics at Aintree University Hospital, Liverpool, UK.
All consenting adults over 18 years old with asthma or
bronchiectasis, who did not meet safety exclusion criteria
(see Table 1), were recruited.
Sputum induction
Participants underwent sputum induction on one
occasion each in August-October 2013. Pre-procedure
Salbutamol (200 micrograms) was given to prevent
bronchoconstriction. Baseline spirometry was performed
to European Respiratory Society and American Thoracic
Society standards [18] using a MicroMedical MicroLab
Mk8 Spirometer (Cardinal Health UK). Three × 5mls of
hypertonic saline (3 %, 4 %, 5 % saline given in stepwise
fashion, lasting up to 5 min per nebulisation) were nebu-
lised via Omron NE-U17 Ultrasonic Nebuliser (Omron
Healthcare Europe). Lung function was assessed at inter-
vals to detect bronchoconstriction, according to pre-
specified safety criteria.
Sputum processing
Sputum samples were kept on ice and sputum plugs were
manually extracted and treated with 0.1 % Sputolysin
(Merck Chemical Ltd, UK) for fifteen minutes to remove
mucus. Phosphate Buffered Solution (Sigma-Aldrich,
UK) was added and cells were filtered and centrifuged
at 2200 rpm for ten minutes at 4 °C (Heraeus Mega-
fuge 1.0R, ThermoFisher Scientific, USA). The pellet
was re-suspended at 0.5×106 cells per ml and two ×
100 μl of suspension was cytocentrifuged (Shandon
Cytopsin 4, ThermoFisher Scientific) onto microscope
slides at 450 rpm for 6 min to produce three cytos-
pins per participant. Slides were fixed in methanol
and stored until staining. One slide per participant was
stained using Hemacolor Staining kit (Merck-Millipore,
Germany) for ImageJ analysis. One slide was stained using
Hemacolor Solution 2 (eosin) only (dipped for 9 s), so that
only the cytoplasm was stained (a method previously de-
veloped for optimising Image SXM analysis [16]). One
slide per participant was stained with Diff-Quik (Dade
Behring, Deerfield, IL, USA) for differential cell counts :
400 cells were counted per participant, using a Leica DM
IL light microscope at ×40 magnification. Cytospins with
a leukocyte/squamous epithelial cell ratio of ≤5 were
Table 1 The exclusion criteria used for safety reasons prior to
performing sputum induction
Safety checklist – exclusion criteria for sputum induction
• FEV1 < 60 %/< 1.0 L (post – Salbutamol 200 micrograms)
• SaO2 < 90 % on room air
• Unable to take salbutamol
• Extreme shortness of breath
• Acute Respiratory Distress Syndrome
• Known haemoptysis
• Known arrhythmias/angina
• Known thoracic, abdominal or cerebral aneurysms
• Recent pneumothorax
• Pulmonary emboli
• Fractured ribs/recent chest trauma
• Recent eye surgery
• Known pleural effusions
• Pulmonary oedema
Thrombocytopenia (Platelets < 25)
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deemed inadequate and therefore excluded from the
analysis [19].
Digital image acquisition
Cytospin slides for ImageJ analysis were photographed
at ×60 magnification using Nikon Eclipse 80i digital
microscope (Nikon Instruments Europe BV) with
Nikon NIS-Elements BR software; 50 macrophages
were captured per participant where possible (in cases
where less than 50 macrophages were present on the
cytospin a reduced number was used). Slides for
Image SXM analysis were imaged at ×40 magnifica-
tion using a Leica DM IL light microscope (Leica
Microsystems UK Ltd) with a Nikon E990 digital
camera (Nikon Inc, USA); where possible 50 micro-
scope fields (with at least one macrophage per field)
were captured per participant - all the macrophages
captured in a field were analysed. In cases where less
than 50 images from the whole cytospin contained a
macrophage this reduced number of macrophages-
containing images, and all macrophages within those
images, were included in the analysis. Images for both
methods were taken systematically using a predefined
method to prevent duplication or biased image selec-
tion, as shown in Fig. 1.
Image SXM analysis
Images were edited using Adobe Photoshop Elements
v6.0 to show only macrophages, to prevent incorrect cal-
culations of cellular and PM areas (Fig. 2a and b). Image
SXM (version 1.92, April 2011) variable settings were
optimised for cytoplasm (upper and lower size limits
and density threshold) and PM (density threshold) de-
tection by adjusting settings for a range of images from
different participants. Values which consistently maxi-
mised identification of PM without increasing false
positive identification were used. These settings were
then applied to the analysis of all images from all
participants. 50 images per participant were analysed
to generate output images (Fig. 2c) and the arithmetic
mean percentage of total cellular area occupied by
PM was calculated by Image SXM. The blink com-
parison function, which provides an overlay of images,
was used to compare original and output images; sub-
jective discordance between total cellular or PM area
led to removal of that image from the analysis. Partic-
ipants with fewer than ten images remaining were ex-
cluded from the analysis.
ImageJ analysis
A stage micrometer (Agar Scientific, UK) was used to
calibrate image size. Colour images were converted to
32-bit black and white images using ImageJ (version
1.46r). The “threshold” settings were adjusted to ob-
tain the best fit of red over black areas [6] (Fig. 1d
and e). The freehand select function was used to se-
lect PM (Fig. 2f ) that was within the cell, and to ex-
clude red areas other than PM, such as nucleus.
ImageJ calculated the area of PM within the selection.
Thresholds were adjusted to obtain the best fit for
different particle aggregates in each macrophage. The
median area from 50 macrophages was calculated.
This methodology is a refinement of previously used
techniques [12], adapted from earlier Scion Image
methodology [10].
Feasibility comparison of methods
The time taken for image capture and analysis of the
final 11 samples was recorded, along with an inventory
of the required equipment and expertise for each
method.
Statistical analysis
Data was analysed using SPSS v21. AMPL given by each
method were compared using a Spearman Rank Order
Correlation test. Participant characteristics were com-
pared using Chi-square and Mann–Whitney U tests.
Time taken to conduct the analyses was compared by
Wilcoxon Signed Rank test. A p value of <0.05 was con-
sidered statistically significant.
Ethical approval
The East Midlands – Derby 1 Research Ethics Committee
approved this work (REC reference: 11/EM/0269).
Written informed consent was obtained from all
participants.
Fig. 1 Systematic digital image acquisition. The pathway used to
acquire digital images of cytospin ‘spots’ is shown
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Results
Sputum induction
21 participants were recruited and attended for sputum
induction and 1 participant was excluded due to baseline
hypoxia (28 other recruited participants failed to attend).
Of 20 participants undergoing sputum induction, sam-
ples were successfully obtained from 19 (Fig. 3). No
adverse events occurred. Cytospins from six (32 %) partic-
ipants were inadequate due to their leukocyte/squamous
epithelial cell ratio. The characteristics of the 13 partici-
pants who provided an adequate sample are shown in
Table 2. There was no significant difference in characteris-
tics between those who provided an adequate sample and
those who did not (data not shown). The differential cell
counts are shown in Table 3.
Feasibility of methodology
Median time for analysis of each participant was signifi-
cantly lower for Image J (26 mins, interquartile range
(IQR): 21–30) than for Image SXM (54 mins, IQR: 43–68),
p = 0.008. Including the time taken for image acquisition,
the median time was not significantly different between
ImageJ (51 mins,IQR: 46–65 mins) and Image SXM
(66 mins, IQR: 59 – 84), p = 0.424. For the Image
SXM method, 58 % of the ‘analysis time’ was spent
editing the images prior to analysis. A comparison of
the resources required for each method is shown in
Table 4.
A mean of 49 macrophages per participant were in-
cluded in the ImageJ analysis (total 632 macrophages). A
mean of 43 images of per participant were captured for
Image SXM analysis (total 558 images). During the
Image SXM process, 72 % of images were removed fol-
lowing the initial analysis as they were deemed to be in-
accurate (either over- or under-estimating AMPL) using
the blink comparison function (Fig. 4), resulting in a fur-
ther four participants being excluded from the study.
The analysis was repeated with only the remaining 143
Fig. 2 Image SXM and ImageJ methodology. Image SXM (a, b & c); digital images of the cytospins (a) were manually edited to remove all non-
macrophage cells and debris (b). Image SXM then calculated the area of cytoplasm [27] and particulate matter (red), mapped out in the output
image (c). ImageJ (d, e & f): for each macropghage, the threshold level was adjusted manually until the black areas of particulate matter seen in
the original image (a) turned red (b). The particulate matter within the cytoplasm was then selected by freehand (c)
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images (median 14 images (IQR 11.5-20) per partici-
pant). If only these nine participants are included, me-
dian time taken increased to 67 mins (IQR 47–72) for
Image SXM analysis and 83 mins (IQR 64–87) including
image acquisition time.
Airway macrophage particulate load
Considerable morphological heterogeneity was seen be-
tween AM, both within samples and between participants,
with wide variations in AMPL (Fig. 5). The cytoplasms of
the AM in this study were noted to be granular and het-
erogeneous (Fig. 5), unlike the homogenous appearance of
cytoplasm seen in our previous experience of macro-
phages obtained by BAL [11].
ImageJ analysis of 13 cytospins revealed a median
AMPL of 0.38 μm2 (IQR 0.17-0.72 μm2). Image SXM
analysis of 9 cytospins calculated a median total cellular
area occupied by PM of 4.0 % (IQR 2.3-6.0 %). There
was no statistically significant correlation between re-
sults obtained using the two methods (correlation coeffi-
cient = −0.42, p = 0.256).
Discussion
A biomarker which can be used in the field to assess an
individual’s air pollution exposure will be a valuable tool
for research into the health effects and benefits of inter-
ventions. In our pilot work for the Cooking and Pneu-
monia Study (www.capstudy.org) we identified the need
for a biomarker representative of household air pollution
exposure [8]. This study set out to explore the feasibility
of using IS samples for assessment of AMPL as a poten-
tial biomarker.
Although the procedure was well-tolerated by all par-
ticipants who underwent IS, there was a low appoint-
ment attendance rate despite multiple appointments
being offered at their convenience. This may be due to
participant’s availability, but may also reflect an unwill-
ingness to undergo the procedure suggesting that IS
Fig. 3 Participants and samples. The flow chart shows the number of consented and recruited patients, and how many samples were obtained
and included in the final analysis
Table 2 Characteristics of 13 participants
Participant characteristic
Gender Male, n (%) 9 (69)
Female, n (%) 4 (31)
Age Years, median (IQR) 57 (39–67)
Respiratory diagnosis Asthma, n (%) 8 (62)
Bronchiectasis, n (%) 2 (15)
Both, n (%) 3 (23)
Smoking status Never smoked (%) 8 (62)
Ex-smoker (%) 5 (38)
Spirometry FEV1, median (IQR), litres 1.80 (1.47-2.26)
FEV1 % Predicted, median
(IQR)
73.5 (60.1 - 77.6)
FVC, median (IQR), litres 2.8 (2.47 – 3.82)
FVC % predicted,
median (IQR)
91.2 (87.6 – 109.0)
IQR Interquartile Range
Jary et al. BMC Pulmonary Medicine  (2015) 15:137 Page 5 of 9
may not be acceptable to the wider community. A third
of participants were unable to produce adequate sam-
ples. These factors resulted in a small samples size, a
major limitation of this study, but also reflects a poten-
tial limitation in the feasibility of using IS as a
biomarker.
The time taken for the Image SXM method was
substantially lengthened by the need to manually edit
images prior to analysis to improve accuracy. This edit-
ing is not required when using this software with BAL
samples, which tend to have few other cells or debris.
ImageJ was the quicker method for image acquisi-
tion and analysis (median 51 min). Image capturing
software used in this study for the ImageJ method de-
layed this process by approximately 15 min, but was
not used for the Image SXM method – a limitation
of this study due to the lack of available equipment.
However, when combined with the time taken for
sputum induction and processing (usually >90 min),
this process is unlikely to be feasible for widespread
use in large studies given the total time required
(>2 h per participant).
Both methods require considerable expenditure for
clinical and laboratory equipment. Previously published
studies using ImageJ method report using a microscope
with a x100 objective, while the Image SXM method re-
quires a x40 objective, both with digital image acquisi-
tion capabilities. In this study a x60 objective was used
for the ImageJ method, as greater magnification was not
available with digital image capturing capabilities. Al-
though this may have theoretically reduced the accuracy
of the ImageJ methodology in our study, we experienced
no difficulties visualising particulate matter within the
macrophages and still found ImageJ to be the more reli-
able of the two methods for detecting PM. As we do not
comment on the accuracy of the ImageJ method in com-
parison to a gold standard assessment of exposure, this
limitation of our study does not have a major impact on
our findings. However, it does emphasise the need for
specialised equipment, which has implications for
feasibility.
Both softwares are available free of charge but ImageJ
is more widely compatible. Image editing software must
be also purchased if using Image SXM with IS. The facil-
ities and equipment required for inducing and process-
ing sputum are likely to preclude the use of this
technique in rural or resource poor settings.
A further limitation of this study is that image capture
of macrophages – which can be difficult to differentiate
from other cell types (particularly on cytospins stained
only with eosin for Image SXM analysis) - was only per-
formed by one reader, with support from a senior cell
biologist, without a priori criteria for inclusion. This
may have resulted in incorrect identification of some
cells. Independent image capture and slide analysis by
two individuals with a high level of expertise may
Table 3 Differential cell counts
Cell type Cell count % (Median (IQR) of 13 participants)
Neutrophil 72.5 (51.1-90.1)
Macrophage 10.0 (4.1-25.8)
Eosinophil 1.6 (1.0-8.5)
Lymphocyte 2.3 (1.2-3.5)
Metachromatic 0.0 (0.0-0.0)
Bronchial epithelial 2.8 (1.1-12.6)
Squamous epithelial 2.3 (0.8-6.5)
Table 4 Comparison of resource requirements for methods
Resource Image SXM ImageJ
Equipment required for sputum induction and
sample processing
Identical specialist equipment and facilities required regardless of
analysis method
Image acquisition equipment Microscope with x40 objective and digital
image capturing capabilities
Microscope with x100a objective and
digital image capturing capabilities
Analysis software availability In the public domain – available free of
charge
In the public domain – available free
of charge
Additional image editing software Purchase required Not required
Operating system for analysis software Compatible with Mac operating systems Compatible with Mac and Windows
operating systems
File type availability TIFF JPEG, TIFF, GIF, BMP, DICOM, FITS and
‘raw’
Time required for sputum induction and
processing
Approximately 90–120 min per participant
Time required for image acquisition (median) 15 min 27 min
Time required for image analysis (including
image editing if required) (median)
54 min 26 min
aAlthough a x100 objective is recommended for ImageJ methodology, a x60 objective was used in this study due to resource limitations
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improve accuracy of macrophage identification, although
this represents an additional challenge for implementing
these methods in resource limited settings.
ImageJ method requires higher levels of operator
training for image analysis than Image SXM, due to the
subjective nature of the analysis process. Further work
to assess intra- and inter-observer reliability using the
ImageJ method is required before this is widely used –
this was not evaluated as part of this study in which only
one unblinded reader performed the analysis.
Although previously successfully used with BAL sam-
ples, Image SXM appears to not perform as well with IS
macrophages. This is possibly due to the heterogenous
and granular nature of these macrophages making it dif-
ficult for the software to distinguish between cytoplasm
and PM, as has been observed in previous studies [14].
We postulate that the difference in appearance com-
pared to BAL macrophages is either due to these being a
different population of macrophages, taken from a more
proximal part of the airways, or due to cell stress or
Fig. 4 An example of inaccurte Image SXM analysis. Comparing the original image (a) to the output image (b), the total cellular area [27]
of the airway macrophage on the left has been overestimated, and the partcilate matter (red) of the airway macrophage on the right
has been overestimated
Fig. 5 Airway macrophage heterogeneity. The morphology of the airway macrophages (shown with red arrows) was varied within the same
sample (a) and between different participant samples (a & b). The particulate load also varied between macrophages in the same sample (a)
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apoptosis resulting from the IS process, although we did
not measure cell viability in this study. Steps were taken
to ensure threshold settings were optimised for this
batch of images, but due to the heterogeneity seen these
settings were not always optimal for each individual
image. Image SXM does include an option to adjust the
threshold settings manually for different images. This
might improve accuracy but would make the process
more time-consuming, and would not account for
heterogeneity of macrophages within the same image
(Fig. 5). Optimising the threshold settings for each image
might reduce the number of images discarded from
Image SXM following visual checking for accuracy
(Fig. 4). This might increase the sample size and there-
fore the precision of estimates.
The lack of correlation observed in AMPL results be-
tween the two methods is unsurprising given some of
the difficulties outlined above. To determine the accur-
acy of either method, comparison with an external com-
parator is required, such as an individual’s PM exposure
data. This, and assessment of intra- and inter-observer
reliability, were beyond the scope of this study. An asso-
ciation between AMPL calculated and the number of
peak exposures to PM has been demonstrated in London
cyclists [20], but further exploration of this relationship
in other settings is required. The results obtained by the
ImageJ method in this study are comparable to that of
healthy British children (0.41 μm2 PM per macrophage)
[13]. Other studies using ImageJ methodology have sug-
gested that AMPL does correlate with exposure [10, 13].
Given the fundamental role of alveolar macrophages in
the defence against inhaled pollutants, further exploration
of the relationship between AMPL and pathophysiology is
an intuitive way to improve understanding of the health
impacts of air pollution. Optimising digital analysis soft-
ware or using alternative methods for quantifying AMPL,
such as spectrophotometry, may assist with this, but is un-
likely to provide a useful field biomarker of exposure.
Conclusion
Direct measurement of air pollution exposure is costly,
logistically complicated and intrusive to the individual.
Studies investigating the health impacts of air pollution
exposure and the benefits of interventions are limited by
the challenges associated with accurately quantifying
exposure [9]. A biomarker of air pollution exposure will
be a useful tool to facilitate research addressing the high
burden of disease associated with air pollution. This
small study has not established whether AMPL is an ac-
curate biomarker of pollution exposure, but has com-
pared the feasibility of two previously used methods.
The heterogeneity of IS samples complicates digital
image analysis methods, and the resource requirements
for assessing AMPL from IS are considerable, making it
unlikely that this biomarker of exposure will be appro-
priate for widespread use as a tool for large-scale inter-
vention studies. Priority should be given to developing a
point-of-care biomarker of exposure, without the need
for specialist training and equipment, to facilitate the
large public health intervention trials that are urgently
needed. Potential biomarkers requiring further explor-
ation include direct measures of combustion products,
such as exhaled carbon monoxide, exhaled carboxy-
haemoglobin, exhaled volatile organic compounds or
levoglucosan and methoxyphenols in urine [8, 9, 21–23].
Indirect measures of exposure in sputum, blood and
urine, including markers of oxidative stress and endothe-
lial or epithelial damage (such as 8-isoprostane, malon-
dialdehyde, nitric oxide, or surfactant-associated protein
D), may also be promising biomarkers [9, 21, 24–26].
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